|
| |
Terms and Acronyms related to Genetics for Genetic
Consumers
Compiled by Wendy Ricker for the Consumer Concerns Committee
of the New England Regional Genetics Group
-
- AAP
- American Academy of Pediatrics, a professional organization. It has
developed standards of care for some genetic conditions.
- ABCG
- American Board of Genetic Counseling. It provides accreditation for
training programs in genetic counseling and certifies master's level genetic
counselors.
- ABMG
- American Board of Medical Genetics, a specialty board of the American
Board of Medical Specialists. It accredits training programs in medical
genetics and certifies medical geneticists (doctoral level practitioners).
- ACMG
- American College of Medical Genetics, a professional organization. It
sets standards of practices for medical geneticists as well as standards and
guidelines for laboratory genetics.
- ACOG
- American College of Obstetrics and Gynecology, a professional
organization. It develops standards of care during pregnancy, which include
recommendations about prenatal screening for possible genetic conditions.
- ADA
- Americans with Disabilities Act, a federal civil rights law. It protects
people with disabilities and genetic predispositions from discrimination in
a number of areas.
- AFP
- Alpha-FetoProtein. This is "a substance made by a developing fetus which
can be measured in a pregnant woman's blood or amniotic fluid . . . " (Weiss
& Mackta, 1996, p. 137). Unusually high or low values for the length of
the pregnancy may suggest the baby has a condition such as spina bifida or
Down syndrome or certain other conditions.
- AG
- Attorney General. This is the head lawyer for county, state, or federal
governments.
- AGSG
- Alliance of Genetic Support Groups, "a national coalition of voluntary
genetic organizations, consumers, and professionals, funded in part by the
Genetic Services Branch of the [federal] Maternal and Child Health Bureau;
[it links] "individuals and families to appropriate genetic support groups
and services" (Weiss & Mackta, 1996, p. 124). It is the national
consumer voice for the regional genetic networks (see CORN). It also
provides a consumer voice in federal policy making and in other areas.
- Allele
- Alleles are "the alternative forms of genes which occur at the same site
on a chromosome and which determine alternative forms of a trait" (Weiss
& Mackta, 1996, p. 136).
- Amino acids
- A set of 20 different molecules of a particular type which make up all
the proteins in the human body or other living things (NCI, 1995).
- Amniocentesis
- "The removal of a sample of amniotic fluid, the fluid surrounding the
growing baby (fetus)" (Weiss & Mackta, 1996, p. 137).
- ART
- Assisted Reproductive Technology. These are highly sophisticated
techniques to help couples who have longstanding difficulties in conceiving
a baby. It includes in-vitro fertilization (see IVF).
- ASHG
- American Society of Human Genetics, a professional organization. Members
include research scientists as well as clinicians in the field of genetics.
- Autosome
- "Chromosomes other than the sex (X or Y) chromosomes. Humans have
twenty-two pairs of autosomes, numbered 1 through 22" (Weiss & Mackta,
1996, p. 137).
- BRCA1
- "A gene that normally helps to restrain cell growth" (NCI, 1995, p.25).
- BRCA1
- breast cancer susceptibility gene "a mutated version of BRCA1, which
predisposes a person toward developing breast cancer" (NCI, 1995, p.25).
- CAP
- College of American Pathologists, a professional organization. (Many
laboratories are headed by pathologists.) This group sets standards for
laboratories, although the standards are not specific to genetic testing.
This organization does "proficiency testing" of laboratories to be sure they
can get reliable results and interpret their results accurately. This is one
part of the review of laboratories to be sure they meet "CLIA standards"
(see CLIA '88) for federal licensing.
- CAPP
- Collaboration Among Parents and Health Professionals, a project based at
the Federation for Children with Special Needs in Boston, Mass.
- Carrier
- "A person who has a recessive mutated gene, together with its normal
allele. Carriers do not usually develop [the condition] but can pass the
mutated gene on to their children" (NCI, 1995, p. 25).
- Carrier testing
- The goal of these tests is identifying individuals, or couples, who
carry a particular recessive gene allele that would result in a particular
genetic condition if a child were to inherit copies of this allele from both
parents. "Carrier testing is designed for healthy people who have no
symptoms of disease, but who are known to be at high risk [of being a
carrier for the disorder] . . . " (NCI, 1995, p. 25).
- CBA
- Cost-Benefit Analysis. This is an approach to measuring costs versus
benefits in monetary terms in setting public policies regarding health
issues.
- CDC
- Centers for Disease Control and Prevention. This is an agency of the
federal government that has shown increasing interest in the public health
implications of genetics.
- CEA
- Cost-Effectiveness Analysis. This is a way to compare different
approaches which might yield a similar health benefit. Measures may include
years of life, "quality-adjusted life years," the number of people with a
condition, or "cost per year of life saved."
- Chromosome
- "The cellular structure that stores and transmits genetic information.
Chromosomes are composed of genes linked together in specific arrangements.
The normal number of chromosomes in humans is forty-six" (Weiss &
Mackta, 1996, p. 138).
- CLIA '88
- Clinical Laboratory Improvement Act of 1988. This legislation is the
basis for the regulations which must be met for a laboratory to receive a
federal license. However, the regulations are not specific to genetic
testing. (See CAP.)
- Clone
- "A group of identical genes, cells, or organisms derived from a single
ancestor" (NCI, 1995, p. 26).
- CORN
- Council of Regional Networks for Genetic Services. This is a "national
umbrella organization, funded by the Genetic Services Branch of the
[federal] Maternal and Child Health Bureau; [it represents] the ten regional
genetic networks. Composed of providers and consumers of genetic services,
CORN coordinates and implements national activities in data collection,
quality assurance, public and professional education, new technologies,
ethical considerations, and funding for services" (Weiss & Mackta, 1996,
p. 124).
- CPT
- Physicians Current Procedural Terminology. The American Medical
Association provides a set of five digit codes for medical procedures to be
used for insurance purposes. The codes reflect what system of the body was
involved and what service was provided. These codes faciliate processing of
insurance claims. There are also associated diagnosis codes.
- CRG
- Council for Responsible Genetics. This is an advocacy group which brings
together scientists, educators, journalists, students, and policy makers on
issues related to the uses and potential misuses of genetics.
- Crossing over
- "A phenomenon, also known as recombination, that sometimes occurs during
the formation of sperm and egg cells (meiosis); a pair of chromosomes (one
from the mother and the other from the father) break and trade segments with
one another" (NCI, 1995, p. 26).
- CVS
- Chorionic Villus Sampling. This is a diagnostic procedure sometimes used
early in pregnancy (at 9 to 11 weeks of growth) to detect certain genetic
disorders.
- Deletion
- "The loss of a portion of a chromosome as a result of chromosome
breakage" (Weiss & Mackta, 1996, p. 138).
- DNA
- Deoxyribonucleic Acid. It is "the substance of heredity; a large
molecule that carries the genetic information necessary for the replication
of cells and for the production of proteins, which are essential for growth,
the building of new tissue, and the repair of injured or broken-down tissue"
(Weiss & Mackta, 1996, p. 138).
- DNA probe
- "A specific sequence of single-stranded DNA used to seek out a
complementary sequence in other single strands" (Weiss & Mackta, 1996,
p. 138).
- DOE
- Department of Energy. This part of the federal government is one source
of funding for the Human Genome Project.
- Dominant allele
- "A gene that is expressed, regardless of whether its counterpart allele
on the other chromosome is dominant or recessive. Autosomal dominant
disorders are produced by a single mutated dominant allele, even though its
corresponding allele is normal. (See recessive allele)" (NCI, 1995, p. 26).
- ELSI
- Ethical, Legal, and Social Implications. This is a portion of the Human
Genome Project that provides funding to examine the broader implications of
the identification of genes. This has included the ELSI working group and
several task force projects to address some of these concerns plus grants
for a variety of independently proposed projects.
- Enzyme
- "A protein that facilitates a specific chemical reaction" (NCI, 1995, p.
26).
- FDA
- Food and Drug Administration, a federal agency that oversees the safety
of foods, drugs, and cosmetics (1938) and medical devices (1976, 1990).
- FISH
- Flourescent In-Situ Hybridization. This is a specialized laboratory
approach used to study chromosomes.
- Gene
- "A unit of inheritance, a working subunit of DNA. Each of the body's
50,000 to 100,000 genes contains the code for a specific product, typically,
a protein such as an enzyme" (NCI, 1995, p. 27).
- Gene mapping
- This process is part of the Human Genome Project. Researchers are
attempting to create a schematic map which would show "the order [and
location] in which genes, genetic markers, and other landmarks are found
along the chromosomes." (NCI, 1995, p. 10 -- see for more detail.)
- GENES
- Genetic Network of New York State, Puerto Rico, and the Virgin Islands,
one of the ten regional genetics networks.
- Gene testing
- "Examining a sample of blood or other body fluid or tissue for
biochemical, chromosomal, or genetic markers that indicate the presence or
absence of genetic [mutations or genetic disorders]" (NCI, 1995, p. 27),
including evidence of carrier status or a predisposition to developing a
condition which has multifactorial components.
- Gene therapy
- This refers to "a medical procedure that treats a disorder by replacing
the faulty gene" (Weiss & Mackta, 1996, p. 138).
- Genetic engineering
- Scientists are "altering genetic material to study genetic processes,
and potentially, to correct genetic defects" (Weiss & Mackta, 1996, p.
138).
- Genome
- "All the genetic material in the chromosomes of a particular organism"
(NCI, 1995, p. 27), such as the set of genes that make up the human organism
(the human genome), or those that make up other creatures, such as a fruit
fly (the fruit fly genome) or a mouse (the mouse genome).
- Genotype
- This refers an individuals's specific set of alleles for any given set
of genes, whether they are dominant or recessive. This might refer to one
set of genes or the entire set of genes that a person has.
- GLaRGG
- Great Lakes Regional Genetics Group -- Illinois, Indiana, Michigan,
Minnesota, Ohio, Wisconsin, one of the ten regional genetics networks.
- GPGSN
- Great Plains Genetic Service Network -- Arkansas, Iowa, Kansas,
Missouri, Nebaska, Oklahoma, North Dakota, South Dakota, one of the ten
regional genetics networks.
- HCFA
- Health Care Finance Administration. This is the part of the federal
Department of Health and Human Services that deals with Medicare and
Medicaid and state waivers for Medicaid.
- Heterozygote
- This refers to "an individual, sometimes called a carrier, who has two
different alleles [for a specific gene]" (Weiss & Mackta, 1996, p. 138).
- HGP
- Human Genome Project. This is a federally funded, multi-year project to
identify every gene in the set of human chromosomes and to identify their
locations.
- HHS
- Department of Health and Human Services. This is the branch of the
federal government that includes the Maternal and Child Health Bureau and
the National Institutes of Health, as well as the agencies that fund
Medicaid, Medicare, and many other services.
- Homozygote
- This refers to an individual who has two identical alleles of a specific
gene.
- HPHC
- (originally HCHP) Harvard Pilgrim Health Care, (earlier Harvard
Community Health Plan) the current name of a major health insurance provider
created by merger of two providers, both managed care organizations
- HuGEM
- Human Genome Education Model Project. This is a joint project of
Georgetown University Child Development Center and the Alliance of Genetic
Support Groups to develop a collaborative education model for consumers and
health professionals.
- IDEA
- Individuals with Disabilities Education Act (Public Law 101-476). This
is the federal law which continued the original Education of All Handicapped
Children Act (Public Law 94-142).
- IEP
- ndividual Educational Plan. This is a school plan developed jointly by
parents and the school for children with disabilities which affect their
learning (starting at age 3). It details goals and services to be provided
in compliance with federal and state laws.
- IFSP
- Individual Family Service Plan. This is a plan developed jointly by
parents and professionals for families with a child "at risk" for a
disability (birth through age 2).
- Imprinting
- "A biochemical phenomenon that determines, for certain genes, which one
of the pair of alleles, the mother's or the father's, will be active in that
individual" (NCI, 1995, p. 28).
- IRB
- Institutional Review Board. This is a group that reviews plans for
research for such issues as safety and ethics before an organization can
implement the research.
- IVF
- In-Vitro Fertilization. This is a procedure to unite an egg and a sperm
outside the body, in a test tube in a laboratory setting.
- IVF-ET
- In-Vitro Fertilization with Embryo Transfer. This is an assisted
reproductive technology technique (see ART). After the egg and sperm are
united in the laboratory, the fertilized egg (embryo) is placed in
(transferred to) the uterus of a woman for development.
- JCAOH
- Joint Committee on Acceditation of Hospitals. This organization sets
national standards for hospitals, which also impacts standards for
laboratories associated with hospitals.
- Karotype
- A karotype is "a systemized array of chromosomes from a single cell,
prepared by photography, that demonstrates the number and morphology of the
chromosomes" (Weiss & Mackta, 1996, p. 139).
- LEA
- Local Educational Agency. This is a term used in federal laws relating
to education of students with disabilities. It usually means the local
school district.
- Linkage
- "The relationship between two genes, or between an identifiable trait
and a genetic disorder. Genes that are located relatively close to each
other on the same chromosome are said to be linked" (Weiss & Mackta,
1996, p. 139).
- Linkage analysis
- "A gene-hunting technique that traces patterns of heredity in large,
high-risk families, in an attempt to locate a disease-causing gene mutation
by identifying traits that are co-inherited with it" (NCI, 1995, p. 28).
- LRE
- Least Restrictive Environment. This is a term used in federal laws
relating to education of students with disabilities. It refers to a
placement decision about the choice of the most appropriate educational
setting for a particular student -- the one closest to the regular education
environment -- as long as appropriate supports or modifications are provided
which enable this student with a disability to benefit from this educational
setting.
- MARHGN
- Mid-Atlantic Regional Human Genetics Network -- Delaware, District of
Columbia, Maryland, New Jersey, Pennsylvania, Virginia, West Virginia, one
of the ten regional genetics networks.
- Marker
- "A detectable genetic variant. Some closely linked markers can be used
to deduce the presence or absence of disease-producing genes" (Weiss &
Mackta, 1996, p. 139).
- MCHB
- Maternal and Child Health Bureau, an agency under Title V, Health
Resources and Services Adminstration, within the federal Department of
Health & Human Services. This agency is the source of the funding grants
for the regional genetics networks and other state and national programs
related to genetics and maternal and child health.
- MDS
- Minimum Data Set. This refers to data which must be collected by the
regional genetics networks from full service genetics centers. This
information is compiled as a national report on genetic services.
- MOD
- March of Dimes Birth Defects Foundation. This is a national organization
which focuses its literature and funding on disorders present at birth and a
number of genetic conditions.
- Molecule
- "A group of atoms arranged to interact in a particular way; one molecule
of any substance is the smallest physical unit of that particular substance"
(NCI, 1995, p. 28).
- MSAFP
- Maternal Serum Alpha-Fetoprotein. This refers to alpha-fetoprotein found
in the pregnant woman's blood (i.e., maternal serum). (See AFP.)
- MSRGSN
- Mountain States Regional Genetic Services Network -- Arizona, Colorado,
Montana, New Mexico, Utah, Wyoming, one of the ten regional genetics
networks.
- Multifactorial
- "Caused by many genetic and nongenetic factors" (Weiss & Mackta,
1996, p. 139).
- Mutation
- "A change in the number, arrangement, or molecular sequence of a gene"
(NCI, 1995, p.28)
- NCHGR
- National Center for Human Genome Research. This part of the National
Institutes of Health "oversees comprehensive research to develop a human
genetic map, to examine the ethical, legal, and social issues arising from
the research, and to develop the technology that must be transferred to
appropriate users in the medical community and industry" (Weiss &
Mackta, 1996, p. 129).
- NEMA
- Northeast Myelodysplasia Association. This group brings together
professionals and consumers involved in regional spina bifida clinics in New
York and New England.
- NERGG
- New England Regional Genetics Group -- Connecticut, Maine,
Massachusetts, New Hampshire, Rhode Island, Vermont, one of the ten regional
genetics networks. It sponsors committees and projects in the New England
area and is the parent group for the Consumer Concerns Committee. It
publishes The Genetic Resource.
- NIH
- National Institutes of Health. This is an agency within the federal
Department of Health and Human Services. It contains the National Center for
Human Genome Research (see NCHGR). This agency also funds many other
research projects and had sponsored fellowships for doctoral and
post-doctoral level trainees in genetics.
- NSGC
- National Society of Genetic Counselors, a professional organization.
- NORD
- National Organization for Rare Disorders. This is a "coalition of
national voluntary health agencies representing individuals with rare
disorders; [it] provides information . . . , referral, and advocacy for
orphan drugs research" (Weiss & Mackta, 1996, p. 130).
- NTD
- Neural Tube Defect. This refers to an incomplete closing of the neural
tube (which develops into the spinal cord) during development of the embryo
early in pregnancy. This can lead to such conditions as spina bifida or
anencephaly (incomplete development of the brain).
- OB
- Obstetrics/obstretrician. This specialty deals with pregnancy and
delivery.
- OB/GYN
- Obstetrics-Gynecology. This specialty deals with pregnancy, delivery,
and the reproductive system in women.
- ORD
- Office of Rare Disorders. This federal agency within the National
Institutes of Health funds research on rare disorders, those affecting less
than 200,000 people in the United States.
- Orphan Drug Act of 1983
- The federal legislation provided tax incentives and time-limited
exclusive marketing to pharmaceutical companies who developed drugs to treat
rare disorders.
- PacNoRGG
- Pacific Northwest Regional Genetics Group -- Alaska, Idaho, Oregon,
Washington, one of the ten regional genetics networks.
- PCR
- Polymerase Chain Reaction. This is a technique used in molecular biology
to study sections of DNA. It increases the amount of DNA available to use in
genetic testing or research.
- Pedigree
- "A diagram showing a genetic family history and biological relationships
among members of a family, often for several generations" (Weiss &
Mackta, 1996, p. 139).
- Penetrance
- "A term indicating the likelihood that a given gene will actually result
in [a genetic disorder] or disease" (NCI, 1995, p. 29).
- PGD
- Pre-implementation Genetic Diagnosis. This is the testing of a
fertilized egg for genetic disorders after in vitro fertilization (see IVF),
before placing the embryo in the uterus for development.
- PHD/PHS
- Public Health Department/Public Health Service. These are federal and
state agencies which provide funding for services linked to public health
issues.
- Phenotype
- "The physical characteristics into which genes are translated" (NCI,
1995, p. 27) as a result of the interaction of genes and the environment,
both before and after birth.
- PI
- Principal Investigator. This term refers to the lead individual in a
project or research grant.
- PL 94-142
- Public Law 94-142, Education of All Handicapped Children Act. This is
the original federal law establishing the rights of children with
disabilities to receive a free, appropriate public education in the least
restrictive setting. It applied to all schools receiving federal funding for
students from ages 5 through 20.
- PL101-476
- Public Law 101-476, Individuals with Disabilities Education Act. This
was the federal law which reauthorized (legislatively continued) the rights
of children with disabilities to a free, appropriate public education. Part
B of the law applied to children from ages 3 through 20. Part H provided a
broader range of services from birth through age 2.
- Predictive gene tests
- "Tests to identify gene [mutations] that may make a person susceptible
to certain diseases or disorders" (NCI, 1995, p. 29).
- Prenatal diagnosis
- "Examining fetal cells taken from the amniotic fluid, the primitive
placenta (chorion), or the umbilical cord for biochemical, chromosomal, or
gene alterations" (NCI, 1995, p. 29).
- PRIM & R
- Public Responsibility in Medicine & Research. This is a group that
advocates for ethical human and animal research.
- PSRGN
- Pacific Southwest Regional Genetics Network -- California, Hawaii,
Nevada, one of the ten regional genetics networks.
- PUBS
- Percutaneous Umbilical Blood Sampling. This is a procedure to take a
blood sample from the baby's umbilical cord prenatally.
- QA
- Quality Assurance. This has been applied to controlling quality in
laboratory testing to be sure test results are accurate, reliable, and
meaningful and interpreted appropriately.
- Recessive allele
- This is "a gene that is expressed only when its counterpart allele on
the matching chromosome is also recessive (not dominant). Autosomal
recessive disorders develop in persons who receive two copies of the mutant
gene, one from each parent who is a carrier. (See Dominant allele.)" (NCI,
1995, p. 29).
- Recombinant DNA
- "The hybrid DNA produced in the laboratory by joining pieces of DNA from
different sources" (Weiss & Mackta, 1996, p. 139).
- Regional genetics network
- one of ten regions of the United States included in the Council of
Regional Networks for Genetic Services (see CORN).
- Genetic Network of New York State, Puerto Rico, and the Virgin Islands
(GENES)
- Great Lakes Regional Genetics Group (GLaRGG) -- Illinois, Indiana,
Michigan, Minnesota, Ohio, Wisconsin
- Great Plains Genetic Service Network (GPGSN) -- Arkansas, Iowa,
Kansas, Missouri, Nebaska, Oklahoma, North Dakota, South Dakota
- Mid-Atlantic Regional Human Genetics Network (MARHGN) -- Delaware,
District of Columbia, Maryland, New Jersey, Pennsylvania, Virginia, West
Virginia
- Mountain States Regional Genetic Services Network (MSRGSN) -- Arizona,
Colorado, Montana, New Mexico, Utah, Wyoming
- New England Regional Genetics Group (NERGG) -- Connecticut, Maine,
Massachusetts, New Hampshire, Rhode Island, Vermont
- Pacific Northwest Regional Genetics Group (PacNoRGG) -- Alaska, Idaho,
Oregon, Washington
- Pacific Southwest Regional Genetics Network (PSRGN) -- California,
Hawaii, Nevada
- Southeast Regional Genetics Group (SERGG) -- Alabama, Florida,
Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina,
Tennessee
- Texas Genetics Network (TEXGENE) -- Texas
- RFP
- Research Funding Proposal. Agencies that grant monies announce what
types of applications would be preferred and outline the steps to be taken
by applicants.
- RNA
- Ribonucleic Acid. This is "a chemical similar to DNA. The several
classes of RNA molecules play important roles in protein synthesis and other
cell activities" (NCI, 1995, p. 30).
- Section 504
- Federal civil rights law, a specific section of Rehabilitation Act of
1973. This protects people with disabilities from discrimination when
certain programs receive federal funding.
- SERGG
- Southeast Regional Genetics Group -- Alabama, Florida, Georgia,
Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee,
one of the ten regional genetics networks.
- Sex chromosomes
- "The chromosomes (X and Y) involved in sex determination. Normal females
have two X chromosomes in each cell, and normal males have one X and one Y"
(Weiss & Mackta, 1996, p. 139).
- SPRANS
- Special Projects of Regional and National Significance. These are
projects related to genetics which are funded by the federal office of
Maternal and Child Health. They include funding for the regional genetics
networks and their coalition (CORN), as well as projects with time
limitations.
- Teratogen
- A terotogen can be a drug, chemical, physical agent or environmental
condition that results in permanent changes in a developing baby due to
exposure during the pregnancy. Examples would include thalidomide and German
measles.
- TEXGENE
- Texas Genetics Network, one of the ten regional genetics networks.
- Translocation
- "The transfer of all or one part of a chromosome to another location on
the same chromosome or to a different chromosome after chromosome breakage"
(Weiss & Mackta, 1996, p. 139).
- Trisomy
- Trisomy occurs when "there are three members of a given chromosome
instead of the normal pair" (Weiss & Mackta, 1996, p. 140).
- UAP
- University Affiliated Programs. These programs provide
multi-disciplinary services for families with a child with a developmental
disability. The programs are affiliated with certain universities.
- X-linked inheritance
- This "refers to any gene found on the X chromosome or traits determined
by such genes; [it also refers] to the specific mode of inheritance of such
genes" (Weiss & Mackta, 1996, p. 140).
References
National Cancer Institute. 1995. Understanding Gene Testing. U.S.
Department of Health and Human Services, NIH Publication No. 96-3905.
Weiss, Joan O., & Mackta, Jayne S. 1996. Starting and Sustaining
Genetic Support Groups. Johns Hopkins University Press: Baltimore.
corrections 10/97

|